Novartis mulls Alcon options, reports earnings

In its 4Q16 earnings report, Novartis AG (NYSE:NVS; SIX:NOVN) said it is mulling an IPO or spin-out of its Alcon Inc. surgical and vision care division. Sales in the division were $5.8 billion, off 2% in 2016 compared to 2015 at constant currency rates.

In January

Read the full 454 word article

User Sign In